Vivos reported findings from a clinical study first published in October 2025 in the Journal of Clinical Medicine that examined the relationship between obstructive sleep apnea (OSA) severity and dental arch form in adults. The study included 100 participants, with 50 OSA patients and 50 controls. It found that narrower intermolar distance and greater palatal height were associated with higher apnea-hypopnea index, with a reported association of p<0.001. Vivos said its Vivos CARE devices have U.S. FDA 510(k) clearance for adult patients with mild, moderate, and severe OSA, and for children ages 6 to 17 with moderate-to-severe OSA.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202603170845PRIMZONEFULLFEED9673264) on March 17, 2026, and is solely responsible for the information contained therein.
Comments